The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus

<p><strong>Background</strong>: Type 1 DM (T1DM) is caused by an autoimmune destruction of pancreatic ß cells. We proposed a novel stimulation using a low-level laser therapy (LLLT) through acupuncture points to stimuli the stem cells to be adult pancreatic ß cells. This study aime...

Full description

Bibliographic Details
Main Authors: Abdurachman Abdurachman, A Rubiyanto, Suhariningsih Suhariningsih, Hendromartono Hendromartono, A Gunawan
Format: Article
Language:English
Published: DiscoverSys 2018-04-01
Series:Bali Medical Journal
Subjects:
Online Access:https://balimedicaljournal.org/index.php/bmj/article/view/527
id doaj-d08906d284294ac4b8cab55a7aa69908
record_format Article
spelling doaj-d08906d284294ac4b8cab55a7aa699082020-11-25T03:51:06ZengDiscoverSysBali Medical Journal2089-11802302-29142018-04-017171110.15562/bmj.v7i1.527416The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes MellitusAbdurachman Abdurachman0A Rubiyanto1Suhariningsih Suhariningsih2Hendromartono Hendromartono3A Gunawan4Department of Anatomy and Histology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia Traditional Medicine Study Program (BATTRA), Faculty of Vocational Studies, Universitas Airlangga, Surabaya, IndonesiaProfessor, Ph.D., Optoelectronics Medical Physics and Biophysics, Institut Teknologi Sepuluh Nopember (ITS), Surabaya, IndonesiaProfessor, Ph.D., Department of Biophysics, Faculty of Science and Technology, Airlangga University, Surabaya, IndonesiaProfessor, Ph.D., Department of Internal Medicine (Indonesia Center for Diabetes Mellitus Study), Dr. Soetomo Teaching Hospital-School of Medicine, Universitas Airlangga, Surabaya, Indonesia.Professor, Ph.D. Department of Anatomy and Histology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.<p><strong>Background</strong>: Type 1 DM (T1DM) is caused by an autoimmune destruction of pancreatic ß cells. We proposed a novel stimulation using a low-level laser therapy (LLLT) through acupuncture points to stimuli the stem cells to be adult pancreatic ß cells. This study aimed to identify an optimal dose of low-level laser therapy (LLLT) for treatment of type 1 diabetes mellitus (T1DM).</p><p><strong>Methods</strong>: An experimental study was performed with a pretest-posttest control groups design. The intervention was tested in rats (Rattus novergicus, Wistar strain). The rats were made diabetic by injection of streptozotocin (STZ). Rats were treated with different doses of LLLT in 4 groups. The tested laser doses were 0.2 joules (group L1), 0.3 joules (group L2), 0.4 joules (group L3), and 0.5 joules (group L4). The therapy was performed by perpendicularly attaching laser probe to the animal body, at the acupuncture point pishu (BL-20) on respective sides.</p><p><strong>Results</strong>: Rats in the L2 group were performing better compared to others. The highest decrease of blood glucose level was found in group L2. Two rats in the L2 group achieved normal blood glucose level upon laser therapy. The dose of laser therapy in the L2 group of 0.3 joules was found to be the optimum dose.</p><p><strong>Conclusion</strong>: Clinical and statistical analyses indicated that 0.3 joule was the optimal dose for LLLT in our animal model. Further investigation of LLLT in human is warranted and validation of the identified dose in future studies should be pursued.</p>https://balimedicaljournal.org/index.php/bmj/article/view/527low-level laser therapy, type 1 dm, optimal dose
collection DOAJ
language English
format Article
sources DOAJ
author Abdurachman Abdurachman
A Rubiyanto
Suhariningsih Suhariningsih
Hendromartono Hendromartono
A Gunawan
spellingShingle Abdurachman Abdurachman
A Rubiyanto
Suhariningsih Suhariningsih
Hendromartono Hendromartono
A Gunawan
The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
Bali Medical Journal
low-level laser therapy, type 1 dm, optimal dose
author_facet Abdurachman Abdurachman
A Rubiyanto
Suhariningsih Suhariningsih
Hendromartono Hendromartono
A Gunawan
author_sort Abdurachman Abdurachman
title The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
title_short The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
title_full The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
title_fullStr The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
title_full_unstemmed The optimal dose of the Low-level laser therapy in the treatment of type 1 Diabetes Mellitus
title_sort optimal dose of the low-level laser therapy in the treatment of type 1 diabetes mellitus
publisher DiscoverSys
series Bali Medical Journal
issn 2089-1180
2302-2914
publishDate 2018-04-01
description <p><strong>Background</strong>: Type 1 DM (T1DM) is caused by an autoimmune destruction of pancreatic ß cells. We proposed a novel stimulation using a low-level laser therapy (LLLT) through acupuncture points to stimuli the stem cells to be adult pancreatic ß cells. This study aimed to identify an optimal dose of low-level laser therapy (LLLT) for treatment of type 1 diabetes mellitus (T1DM).</p><p><strong>Methods</strong>: An experimental study was performed with a pretest-posttest control groups design. The intervention was tested in rats (Rattus novergicus, Wistar strain). The rats were made diabetic by injection of streptozotocin (STZ). Rats were treated with different doses of LLLT in 4 groups. The tested laser doses were 0.2 joules (group L1), 0.3 joules (group L2), 0.4 joules (group L3), and 0.5 joules (group L4). The therapy was performed by perpendicularly attaching laser probe to the animal body, at the acupuncture point pishu (BL-20) on respective sides.</p><p><strong>Results</strong>: Rats in the L2 group were performing better compared to others. The highest decrease of blood glucose level was found in group L2. Two rats in the L2 group achieved normal blood glucose level upon laser therapy. The dose of laser therapy in the L2 group of 0.3 joules was found to be the optimum dose.</p><p><strong>Conclusion</strong>: Clinical and statistical analyses indicated that 0.3 joule was the optimal dose for LLLT in our animal model. Further investigation of LLLT in human is warranted and validation of the identified dose in future studies should be pursued.</p>
topic low-level laser therapy, type 1 dm, optimal dose
url https://balimedicaljournal.org/index.php/bmj/article/view/527
work_keys_str_mv AT abdurachmanabdurachman theoptimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT arubiyanto theoptimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT suhariningsihsuhariningsih theoptimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT hendromartonohendromartono theoptimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT agunawan theoptimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT abdurachmanabdurachman optimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT arubiyanto optimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT suhariningsihsuhariningsih optimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT hendromartonohendromartono optimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
AT agunawan optimaldoseofthelowlevellasertherapyinthetreatmentoftype1diabetesmellitus
_version_ 1724488763566981120